Alliances
Building healthcare's future through strategic alliances
One of adsidera’s main strengths lies in our extensive network spanning business, venture, regulatory, legal, market access, media & communication, technology, and research institutions globally. Through pharma alliance management expertise, we create ecosystems amplifying companies’ value and accelerating results.
Our model connects specialized capabilities with complementary resources that unite through collaborations, ensuring sustainable success. Each relationship delivers measurable value and creates opportunities for projects such as pharmaceutical license agreement deals.
Swiss Legal & IP Consortium
Type: Legal & IP
Expertise: Corporate law, IP protection, licensing in pharmaceutical industry
Geography: Switzerland
Value: Comprehensive legal and trademark expertise through specialized network partners in corporate counsel and intellectual property
European Regulatory Network
Type: Regulatory Affairs
Expertise: EMA submissions, authorizations, GMP/GCP compliance
Geography: Austria, Germany, Netherlands, Italy, France, Ireland
Value: Value: Streamlined EU pathways leveraging specialized regulatory network partners and Andrea Meoli’s alliance healthcare europe connections
North America Market Access
Type: Commercial & Market Access
Expertise: FDA liaison, pricing, reimbursement, health economics
Geography: United States, Canada
Value: North American entry through Andrea Meoli, Hans P. Schmid and Pierfrancesco Ruffo expertise
Media, Technology & Digital Innovation Hub
Type: Media, AI & Digital Health
Expertise: Media relationships, AI implementation, digital therapeutics, clinical technology
Geography: Switzerland, EU, US
Value: Cutting-edge integration and promotion alliances supporting healthcare services through Gaetano Biondo’s martech knowledge and network
Academic & Research Institutions
Type: Research & Clinical Excellence
Expertise: Clinical research, real-world evidence, publications
Geography: US, EU, Switzerland, Japan
Value: Scientific credibility through pharmaceutical advisory board guidance and Pierfrancesco Ruffo’s RWE expertise
MENA & Eastern Europe Partners
Type: Regional Market Specialists
Expertise: UAE regulatory, Eastern European market entry, distribution
Geography: UAE, Eastern Europe
Value: Regional access through Hans P. Schmid’s expertise in these markets
Asia-Pacific Network
Type: Asian Market Development
Expertise: PMDA liaison, NMPA coordination, regional regulatory strategy
Geography: Japan, South Korea, China
Value: APAC expansion leveraging Andrea Meoli’s business and expansion track record
Latin America Partners
Type: Emerging Markets Specialists
Expertise: ANVISA regulatory, market access, local partnerships
Geography: Brazil, Mexico and more
Value: LATAM penetration through Andrea Meoli’s expertise and established networks
Partnership Philosophy
Our pharmaceutical consulting alliance network operates on mutual value creation. Partners share commitment to excellence, innovation, and smart collaboration.
Alliance Benefits
- Cross-referral opportunities globally
- Shared expertise optimization
- Coordinated multi-jurisdiction solutions
- Enhanced credibility through association
- Streamlined execution frameworks
Partnership Governance
Excellence through structured alliance management pharma protocols. Regular summits, coordinated standards, transparent communication, continuous improvement.
Joining our network
Selection Criteria
- Shared values and work ethics
- Proven pharmaceutical/healthcare expertise
- Cross-team and cross-company collaboration history
- Successful delivery track record
- Smart alignment capabilities
- Innovation capacity
Engagement Models
- Strategic long-term alliances
- Project-based partnerships
- Referral collaborations
- Technology synergies
- Academic / Applied Science relationships